Indo Us Bio-Tech Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 221.14 million compared to INR 155.03 million a year ago. Revenue was INR 221.91 million compared to INR 155.06 million a year ago. Net income was INR 36.85 million compared to INR 13.71 million a year ago. Basic earnings per share from continuing operations was INR 1.84 compared to INR 1.37 a year ago. Diluted earnings per share from continuing operations was INR 1.84 compared to INR 1.37 a year ago.
For the nine months, sales was INR 570.7 million compared to INR 436.35 million a year ago. Revenue was INR 571.79 million compared to INR 436.39 million a year ago. Net income was INR 77.27 million compared to INR 44.68 million a year ago. Basic earnings per share from continuing operations was INR 3.85 compared to INR 4.46 a year ago. Diluted earnings per share from continuing operations was INR 3.85 compared to INR 4.46 a year ago.